Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Molecular convergence between Down syndrome and Fragile X syndrome identified using human pluripotent stem cell models

ABSTRACT: Molecular convergence between Down syndrome and Fragile X syndrome identified using human pluripotent stem cell models

PROVIDER: PRJNA605160 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11034917_1.fastq.gz	Fastqsanger.gz
	SRR11034917_2.fastq.gz	Fastqsanger.gz
	SRR11034918_1.fastq.gz	Fastqsanger.gz
	SRR11034918_2.fastq.gz	Fastqsanger.gz
	SRR11034919_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 80

Similar Datasets

Molecular convergence between Down syndrome and Fragile X syndrome identified using human pluripotent stem cell models

Project description:The goal of this study was to define molecular overlap between Down syndrome and Fragile X syndrome using human pluripotent stem cells (hPSCs) and in vitro derived glutamatergic neurons.

2022-08-05 | GSE144857 | GEO

Down Syndrome

Project description:Down Syndrome

| PRJNA804910 | ENA

Molecular convergence between Down syndrome and fragile X syndrome identified using human pluripotent stem cell models.

Project description:Down syndrome (DS), driven by an extra copy of chromosome 21 (HSA21), and fragile X syndrome (FXS), driven by loss of the RNA-binding protein FMRP, are two common genetic causes of intellectual disability and autism. Based upon the number of DS-implicated transcripts bound by FMRP, we hypothesize that DS and FXS may share underlying mechanisms. Comparing DS and FXS human pluripotent stem cell (hPSC) and glutamatergic neuron models, we identify increased protein expression of select targets and overlapping transcriptional perturbations. Moreover, acute upregulation of endogenous FMRP in DS patient cells using CRISPRa is sufficient to significantly reduce expression levels of candidate proteins and reverse 40% of global transcriptional perturbations. These results pinpoint specific molecular perturbations shared between DS and FXS that can be leveraged as a strategy for target prioritization; they also provide evidence for the functional relevance of previous associations between FMRP targets and disease-implicated genes.

| S-EPMC9465809 | biostudies-literature

Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells

Project description:Fragile X syndrome (FXS) is caused by the absence of the fragile X mental retardation protein (FMRP). We have previously generated FXS-induced pluripotent stem cells (iPSCs) from patients' fibroblasts. In this study, we aimed at unraveling the molecular phenotype of the disease. Our data revealed aberrant regulation of neural differentiation and axon guidance genes in FXS-derived neurons, which are regulated by the RE-1 silencing transcription factor (REST). Moreover, we found REST to be elevated in FXS-derived neurons. As FMRP is involved in the microRNA (miRNA) pathway we employed microRNA-array analyses and uncovered several miRNAs dysregulated in FXS-derived neurons. We found hsa-mir-382 to be down-regulated in FXS-derived neurons, and introduction of mimic-mir-382 into these neurons was sufficient to repress REST and up-regulate its axon guidance target genes. Our data link, FMRP and REST, through the miRNA pathway, and show a new aspect in the development of FXS. Affimetrix miRNA array of two WT and two fragile X syndrome derived neurons

2014-10-28 | E-GEOD-62721 | biostudies-arrayexpress

Human pluripotent stem cell-derived astrocyte model in fragile X syndrome

Project description:The experiment was made to compare gene expression of human control (H1) ES-derived astrocytes and isogenic astrocytes carrying a mutation causing fragile x syndrome.

2023-07-21 | GSE228378 | GEO

FMR1 Mutant Marmosets Show Fragile X Syndrome Phenotypes

Project description:Fragile X syndrome (FXS) is the leading monogenic cause of autism spectrum disorder and intellectual disability, caused by silencing of the FMR1 gene. To determine the effect of FMRP loss on the mRNA profile in a marmoset model of FXS, we performed RNA-sequencing of brain samples from neonatal wild-type and FMR1 mutant marmosets.

2025-07-16 | GSE271271 | GEO

Down syndrome SNPs - samples

Project description:Down syndrome SNP genotyping data

| EGAD00010000464 | EGA

Down syndrome CNVs - samples

Project description:Down syndrome CNV genotyping data

| EGAD00010000466 | EGA

FMR1 Mutant Marmosets Show Fragile X Syndrome Phenotypes

Project description:FMR1 Mutant Marmosets Show Fragile X Syndrome Phenotypes

| PRJNA1130839 | ENA

Epigenetic changes in Down syndrome leukemogenesis

Project description:Epigenetic changes in Down syndrome leukemogenesis